1. Foundation for Promotion of Cancer Research, Japan. Cancer Statistics in Japan- 2015. Available at: https://ganjoho.jp/data/reg_stat/statistics/brochure/2015/cancer_statistics_20 15_fig_J.pdf (Accessed 8th April 2020)
2. Alberg A J, Brock M V, Ford J G, et al. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143, 1–29 (2013)
3. Ministry of Health, Labour, and Welfare, Japan. National Vital Statistics in 2014. Available at: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei14/index.html (Accessed 8th April 2020)
4. Foundation for Promotion of Cancer Research Research, Japan. Cancer Statistics in Japan - 2018. Available at: https://ganjoho.jp/data/reg_stat/statistics/brochure/2018/cancer_statistics_20 18_fig_J.pdf. (Accessed 8th April 2020)
5. 日本肺癌学会肺癌診療ガイドライン. Available at: https://www.haigan.gr.jp/modules/guideline/index.php?content_id=3. (Accessed 8th April 2020)
6. Ministry of Health, Labour, and Welfare, Japan. Cancer Incidence of Japan in 2016. Available at: https://www.mhlw.go.jp/content/10900000/000553552.pdf. (Accessed 8th April 2020)
7. National Clinical Database年次報告書 対象データ：2016年1月1日～2016年 12月31日. Available at: https://www.jssoc.or.jp/other/info/info20170811- 02.pdf (Accessed 8th April 2020)
8. 日本CT検診学会．日本における低線量CTによる肺がん検診の考え方． Available at: https://www.jscts.org/index.php?page=guideline_index (Accessed 8th April 2020)
9. Henschke C I, et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 354, 99–105 (1999).
10. Marcus M W, et al. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: The UKLS trial. Thorax 761–767 (2019). doi:10.1136/thoraxjnl-2018-212263
11. Aberle DR, Adams AM, Berg CD, et al. Reduced lung cancer mortality with low-dose computed tomographic screening. Community Oncol. 8, 441–442 (2011).
12. Henschke C I, Yip R, Yankelevitz D F, et al. Definition of a positive test result in computed tomography screening for lung cancer. Ann. Intern. Med. 158, 246–252 (2013).
13. Dai C, et al. New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies. Ther. Clin. Risk Manag. Volume 14, 203– 211 (2018).
14. Morichika D, et al. Peripheral lung cancer: screening and detection with low- dose spi- ral CT versus radiography. Intern. Med. 53, 2795–2799 (2014).
15. Kusumoto M. 末梢小型肺病変のCT診断，特にフォローアップについて. Japanese J. Lung Cancer 56, 999–1002 (2016).
16. Macmahon H, et al. Guidelines for Management of Incidental Pulmonary Nodules MacMahon et al Content code. Radiol. n Radiol. 284, (2017).
17. Young R P, Hopkins R J. CT screening for lung cancer. Thorax 67, 650–651 (2012).
18. Naidich D P, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: A statement from the Fleischner Society. Radiology 266, 304–317 (2013).
19. Suzuki K, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical ia lung cancer (Japan Clinical Oncology Group 0201). J. Thorac. Oncol. 6, 751– 756 (2011).
20. Lee, K. H, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J. Thorac. Oncol. 9, 74– 82 (2014).
21. Kudo, Y, et al. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients. Lung Cancer 90, 47–54 (2015).
22. Meng Y, Liu C L, Cai Q, et al. Contrast analysis of the relationship between the HRCT sign and new pathologic classification in small ground glass nodule-like lung adenocarcinoma. Radiol. Medica 124, 8–13 (2019).
23. Niu R, Shao X, Shao X. Lung Adenocarcinoma Manifesting as Ground-Glass Opacity Nodules 3 cm or Smaller: Evaluation With Combined High-Resolution CT and PET/CT Modality. Am. J. Roentgenol. 213, 1221–1228 (2019).
24. Wu F Z, et al. Semiquantative Visual Assessment of Sub-solid Pulmonary Nodules ≦3 cm in Differentiation of Lung Adenocarcinoma Spectrum. Sci. Rep. 7, 1–10 (2017).
25. Yoon H E, et al. Pulmonary nodules 10 mm or less in diameter with ground- glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy. Japanese J. Thorac. Cardiovasc. Surg. 53, 22–28 (2005).
26. Kobayashi Y, Mitsudomi T. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? Transl Lung Cancer Res 2, 354–363 (2013).
27. Chang M P, et al. Nodular ground-glass opacity at thin-section CT: Histologic correlation and evaluation of change at follow-up. Radiographics 27, 391–408 (2007).
28. Suzuki K, et al. Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi- institutional prospective study. Interact. Cardiovasc. Thorac. Surg. 21, 218–223 (2015).
29. Shimizu K, Ikeda N, Tsuboi M, et al. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung Cancer 51, 173–179 (2006).
30. Rivera M P, Mehta A C, Wahidi M M. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143, (2013).
31. Migliore M, et al. Ground glass opacities management in the lung cancer screening era. Ann. Transl. Med. 6, 90–90 (2018).
32. Korb M L, Burt B M. The elusive ground glass opacity, revealed. J. Thorac. Dis.10, S3828–S3830 (2018).
33. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low- dose helical CT. Chest. 2002;121:1464–1467
34. Ichinose J, et al. Utility of Maximum CT Value in Predicting the Invasiveness of Pure Ground-Glass Nodules. Clin. Lung Cancer 1–7 (2020). doi:10.1016/j.cllc.2020.01.015
35. Oh J Y, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 55, 67–73 (2007).
36. Kuriyama K, Seto M, Kasugai T, et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol 173(2), 465-469 (1999).
37. Qiu Z X, et al. Clinical, pathological, and radiological characteristics of solitary ground-glass opacity lung nodules on high-resolution computed tomography. Ther. Clin. Risk Manag. 12, 1445–1453 (2016).
38. Gao F, et al. CT characterization of different pathological types of subcentimeter pulmonary ground-glass nodular lesions. Br. J. Radiol. 92, (2019).
39. Travis W D, et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 6, 244–285 (2011).
40. Jang H J, Lee K S, Kwon O J, et al. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology 1996;199:485-8.
41. Yoshizawa A. et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases. Mod. Pathol. 24, 653–664 (2011).
42. Bauer R W, et al. Attenuation and Morphologic Characteristics Distinguishing a Ground-Glass Nodule Measuring 5–10 mm in Diameter as Invasive Lung Adenocarcinoma on Thin-Slice CT. Image (Rochester, N.Y.) 9–12 (2009). doi:10.2214/AJR.08.1277
43. Subramanian M, McMurry T, Meyers B F, et al. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection. Ann. Thorac. Surg. 106, 375–381 (2018).
44. Khullar O V, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: An analysis from the National Cancer Data Base. J. Thorac. Oncol. 10, 1625–1633 (2015).
45. Sagawa M, et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur. J. Cardio-thoracic Surg. 53, 849– 856 (2018).
論文の公開元へ
